What we do Makers Laboratories Ltd manufactures pharmaceutical formulations and drug intermediates, focusing on generic drugs and liquid injectables primarily for the Indian healthcare market. |
Founded in 1,984 |
Market share A significant player in India's generic pharmaceutical industry with expanding domestic and export presence. |
Problem solved Provides affordable generic medicines and specialized ophthalmic products to meet healthcare needs domestically and internationally. |
Top clients or who we serve Serves hospitals, nursing homes, dispensing doctors; operates B2B and B2C channels in domestic and overseas markets. |
Key management - |
Our journey and innovations Started in 1984, expanded capacities over decades, merged with related companies, modernized plants, and launched new diabetic and ophthalmic products. |
Where we operate Primarily India with expanding exports targeting Eurasian Economic Union and other international regions. |
Top products or what we offer Generic formulations, new diabetic and hypertensive drugs, ophthalmic eye drops, liquid injectables, chemical manufacturing. |
Top brands - |
Raw materials needed Pharmaceutical raw materials, chemical intermediates used in formulations and injectables. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue largely recurring from pharmaceutical sales with cyclical elements linked to market demand. |
Our industry position Well-established with diverse product segments and regulated certifications enabling export growth. |
Financial highlights FY 2024-25 standalone revenue Rs. 53.87 crore, net profit Rs. 4.64 crore; consolidated revenue Rs. 132.64 crore, profit Rs. 7.49 crore. |
Geographical revenue split Domestic business contributes 86.64%; exports contribute 34.11% of segment revenue. |
Order book - |
Whats driving growth New product launches, plant modernization, regulatory approvals, and growing generic drug demand. |
Our future plans Expand ophthalmic and injectable exports, increase production capacity, and develop new formulations for global markets. |
Our green promise - |
Our people and values 131 employees fostering a quality culture focused on productivity and compliance. |
Key challenges ahead Intense competition, regulatory delays, market price pressures, and dependency on approvals. |
Interesting facts Received Eurasian Economic Union GMP certification for ophthalmic manufacturing site. |
Risks and strategy Mitigates market and regulatory risks via R&D, platform modernization, and diversification. |
